What is the current Drug-eluting PTA Balloon Dilatation Catheter market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Drug-eluting PTA Balloon Dilatation Catheter market?

Increasing demand for minimally invasive procedures and technological advancements drive the market.

What are the major challenges facing the market?

High development costs and stringent regulatory frameworks pose significant challenges.

Which regions are the leaders in the Drug-eluting PTA Balloon Dilatation Catheter market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the market?

Major players include Medtronic, Boston Scientific, and Abbott Laboratories.

What future opportunities can be expected in the market?

Emerging markets and increasing adoption of innovative technologies offer future opportunities.

How will technology impact the Drug-eluting PTA Balloon Dilatation Catheter market?

Advances in materials and design will improve device efficacy and patient outcomes.

What is the current regulatory landscape for the market?

Regulatory frameworks vary by region, with FDA and CE markings being crucial for market approval.

What is the future outlook for the Drug-eluting PTA Balloon Dilatation Catheter market size?

The market is expected to reach USD 2.5 billion by 2033, driven by growing demand.

Drug-eluting PTA Balloon Dilatation Catheter Industry Size, Share & Growth Forecast 2033

Drug-eluting PTA Balloon Dilatation Catheter by Application (Hospital, Clinic, Others), by Types (Balloon Diameters 3-12mm, Balloon Diameters Above 12mm), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Drug-eluting PTA Balloon Dilatation Catheter Market Size | CAGR 7.2 Forecast 2033

Drug-eluting PTA Balloon Dilatation Catheter Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Drug-eluting PTA Balloon Dilatation Catheter Market Overview

The Drug-eluting PTA Balloon Dilatation Catheter market is a crucial segment of the medical device industry, playing a significant role in treating peripheral artery disease. As the global population ages and cardiovascular diseases become more prevalent, the Drug-eluting PTA Balloon Dilatation Catheter market size is poised for substantial growth, with a current estimated market size of approximately $1.3 billion. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by advancements in technology, increasing demand for minimally invasive procedures, and an expanding patient population. The industry expansion is expected to be fueled by rising healthcare expenditures, growing awareness about cardiovascular diseases, and the development of innovative products.

Loading chart…

The Drug-eluting PTA Balloon Dilatation Catheter market is expected to grow at a CAGR of 7.5% during the forecast period, driven by macro drivers such as an aging population, an increase in cardiovascular diseases, and advancements in medical technology. Key forces shaping the industry include technological shifts towards more minimally invasive procedures, regulatory pressures to ensure device safety and efficacy, and competitive intensity among market players. The largest region for Drug-eluting PTA Balloon Dilatation Catheter is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditures and a growing awareness about cardiovascular diseases.

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	8.37 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acotec; Boston Scientific; Abbott; Terumo Europe; MicroPort Scientific; Medtronic; Cordis; B. Braun Melsungen; Natec Medical; Spectranetics; HEXACATH; Alvimedica; Lepu Medical; Demax Medical; Cardionovum
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Drug-eluting PTA Balloon Dilatation Catheter market is witnessing significant transformations, driven by various factors that are shaping its growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Advancements in technology, such as the development of more efficient drug-eluting coatings, are enhancing the efficacy of Drug-eluting PTA Balloon Dilatation Catheter market products, leading to increased adoption rates among medical professionals.

The rising prevalence of peripheral artery disease (PAD) and other vascular conditions is fueling demand for minimally invasive treatments, thereby contributing to the Drug-eluting PTA Balloon Dilatation Catheter market size.

Restraints2 items

Stringent regulatory frameworks and the requirement for extensive clinical trials to ensure safety and efficacy are posing significant challenges to the launch of new Drug-eluting PTA Balloon Dilatation Catheter market products.

The high cost associated with the development and procurement of Drug-eluting PTA Balloon Dilatation Catheter devices is limiting their accessibility in certain regions, thus affecting the overall growth forecast of the market.

Opportunities2 items

Emerging economies present a vast, untapped market for Drug-eluting PTA Balloon Dilatation Catheter manufacturers, with increasing healthcare expenditure and a growing awareness of advanced medical treatments.

The trend towards personalized medicine and the integration of drug-eluting technology with other therapeutic approaches offer opportunities for innovation and expansion in the Drug-eluting PTA Balloon Dilatation Catheter market.

Challenges2 items

The Drug-eluting PTA Balloon Dilatation Catheter market faces challenges related to reimbursement policies, as the coverage and payment for these devices can vary significantly between different healthcare systems.

Maintaining a competitive edge in the market requires continuous investment in research and development, to stay ahead of the curve in terms of technology and clinical outcomes, which can be a significant challenge for manufacturers.

Market Segmentation

Loading chart…

The Drug-eluting PTA Balloon Dilatation Catheter market can be segmented based on Application, which includes femoral artery, popliteal artery, infrapopliteal artery, and other peripheral arteries. This segmentation contributes to the overall market size by highlighting the specific areas where these catheters are used, allowing for a better understanding of the market's dynamics. The femoral artery segment accounts for the largest share of the market, driven by the high prevalence of femoral artery diseases. Understanding the Drug-eluting PTA Balloon Dilatation Catheter segmentation is crucial for industry players to develop targeted strategies and products.

Another way to segment the market is by Types, which includes standard Drug-eluting PTA Balloon Dilatation Catheters and specialty Drug-eluting PTA Balloon Dilatation Catheters. This segmentation helps in understanding the different product offerings in the market and their respective market shares. The standard Drug-eluting PTA Balloon Dilatation Catheters segment dominates the market, due to its widespread adoption and cost-effectiveness. However, the specialty Drug-eluting PTA Balloon Dilatation Catheters segment is expected to grow at a higher rate, driven by the increasing demand for advanced and customized products.

Drug-eluting PTA Balloon Dilatation Catheter Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Balloon Diameters 3-12mm

Balloon Diameters Above 12mm

Regional Insights

Loading chart…

The Drug-eluting PTA Balloon Dilatation Catheter market growth is anticipated to be driven by various factors across different regions. North America is the largest region, accounting for approximately 40% of the market share, driven by key factors such as high adoption rates, favorable policies, and significant investments in healthcare infrastructure. Europe is the second-largest region, with a share of around 30%, driven by factors like demographics, ecosystem maturity, and infrastructure development.

The Asia Pacific region is the fastest-growing region, with a projected regional forecast of 10% annual growth rate, driven by factors such as increasing demand for minimally invasive procedures, growing healthcare expenditure, and improving infrastructure. Latin America and Middle East & Africa are also expected to witness significant growth, driven by factors like government initiatives, rising awareness, and expanding healthcare services.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Europe: demographics, ecosystem maturity, infrastructure development

Asia Pacific: increasing demand, growing healthcare expenditure, improving infrastructure

Latin America: government initiatives, rising awareness, expanding healthcare services

Middle East & Africa: government initiatives, rising awareness, expanding healthcare services

Competitive Landscape

The Drug-eluting PTA Balloon Dilatation Catheter market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Drug-eluting PTA Balloon Dilatation Catheter competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service model, and channel strength. Companies are also investing in research and development to improve product portfolios and expand their reach.

Common strategies employed by companies in this market include mergers and acquisitions, partnerships, product launches, expansion, and research and development. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies are focusing on competitive differentiation through technology, service model, channel strength, customization, and cost advantages. The following companies are notable players in the market:

Acotec: regional expansion

Boston Scientific: innovation pipeline

Abbott: vertical integration

Terumo Europe: premium pricing

MicroPort Scientific: local manufacturing

Medtronic: OEM tie-ups

Key Drug-eluting PTA Balloon Dilatation Catheter Companies15 items

Acotec

Boston Scientific

Abbott

Terumo Europe

MicroPort Scientific

Medtronic

Cordis

B. Braun Melsungen

Natec Medical

Spectranetics

HEXACATH

Alvimedica

Lepu Medical

Demax Medical

Cardionovum

Market Ecosystem

The Drug-eluting PTA Balloon Dilatation Catheter ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of these catheters, which are used to treat vascular diseases. The ecosystem involves various participants who contribute to the design, production, and delivery of these medical devices.

Raw material suppliers — providing materials for catheter production

OEMs/manufacturers — designing and producing catheters

Distributors/channel partners — delivering catheters to healthcare facilities

Service providers/after-sales — offering maintenance and support services

End users/buyers — healthcare professionals and institutions

Regulators/standards bodies — establishing guidelines and approvals

Data/analytics providers — providing insights on catheter performance and outcomes

In the Drug-eluting PTA Balloon Dilatation Catheter ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact production and distribution. Switching costs and partnerships are also critical, as they can affect the interoperability of catheters with other medical devices. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market dynamics. A thorough value chain analysis is necessary to understand these complexities and identify opportunities for growth and improvement.

Recent Industry Insights

The Drug-eluting PTA Balloon Dilatation Catheter industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Cardinal Health, have focused on expanding product portfolios and improving market reach. Additionally, there have been notable mergers and acquisitions, including the acquisition of Boston Scientific's peripheral intervention unit by Cardinal Health, aiming to strengthen their presence in the market.

Furthermore, several product launches have taken place, such as the introduction of new generation Drug-eluting PTA Balloon Dilatation Catheters with enhanced drug delivery mechanisms. Regulatory changes, including the updated guidelines for the use of Drug-eluting PTA Balloon Dilatation Catheters in treating peripheral artery disease, have also impacted the industry. These developments indicate a shift in consumer and enterprise trends towards more effective and minimally invasive treatment options, driving growth in the Drug-eluting PTA Balloon Dilatation Catheter market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Drug-eluting PTA Balloon Dilatation Catheter market outlook. The market attractiveness is high due to increasing demand for minimally invasive procedures and advancements in technology. Competitive intensity is moderate, with key players focusing on innovation and expansion. The long-term outlook is positive, driven by growing awareness and adoption of drug-eluting balloon dilatation catheters. The innovation landscape is evolving, with ongoing research and development of new materials and designs. Demand-supply balance is stable, with manufacturers working to meet the rising demand. However, key risk factors include regulatory challenges and competition from alternative treatments.

11 items

1. Executive Summary

2. Drug-eluting PTA Balloon Dilatation Catheter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Drug-eluting PTA Balloon Dilatation Catheter Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Drug-eluting PTA Balloon Dilatation Catheter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Drug-eluting PTA Balloon Dilatation Catheter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Balloon Diameters 3-12mm

6.2.2. Balloon Diameters Above 12mm

6.3. Global Drug-eluting PTA Balloon Dilatation Catheter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Drug-eluting PTA Balloon Dilatation Catheter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Drug-eluting PTA Balloon Dilatation Catheter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Drug-eluting PTA Balloon Dilatation Catheter Market Competition by Key Manufacturers

8.1. Global Drug-eluting PTA Balloon Dilatation Catheter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Drug-eluting PTA Balloon Dilatation Catheter: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Acotec

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo Europe

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. MicroPort Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Medtronic

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cordis

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. B. Braun Melsungen

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Natec Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Spectranetics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. HEXACATH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Alvimedica

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Lepu Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Demax Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Cardionovum

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Drug-eluting PTA Balloon Dilatation Catheter Market

Figure 4: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Drivers

Figure 5: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Challenges

Figure 6: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Trends

Figure 7: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Opportunity

Figure 8: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Restraint

Figure 9: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Drug-eluting PTA Balloon Dilatation Catheter Market Value (USD Million) By Region

Figure 15: Global Drug-eluting PTA Balloon Dilatation Catheter Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Drug-eluting PTA Balloon Dilatation Catheter Market Value (USD Million) By Region

Figure 23: Global Drug-eluting PTA Balloon Dilatation Catheter Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Drug-eluting PTA Balloon Dilatation Catheter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Drug-eluting PTA Balloon Dilatation Catheter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Drug-eluting PTA Balloon Dilatation Catheter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Drug-eluting PTA Balloon Dilatation Catheter Market Value (USD Million) By Region

Table 10: Global Drug-eluting PTA Balloon Dilatation Catheter Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Drug-eluting PTA Balloon Dilatation Catheter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Drug-eluting PTA Balloon Dilatation Catheter Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Drug-eluting PTA Balloon Dilatation Catheter Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Acotec Basic Information And Sales Area

Table 31: Acotec. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: Abbott Basic Information And Sales Area

Table 35: Abbott. Products Portfolio

Table 36: Terumo Europe Basic Information And Sales Area

Table 37: Terumo Europe. Products Portfolio

Table 38: MicroPort Scientific Basic Information And Sales Area

Table 39: MicroPort Scientific. Products Portfolio

Table 40: Medtronic Basic Information And Sales Area

Table 41: Medtronic. Products Portfolio

Table 42: Cordis Basic Information And Sales Area

Table 43: Cordis. Products Portfolio

Table 44: B. Braun Melsungen Basic Information And Sales Area

Table 45: B. Braun Melsungen. Products Portfolio

Table 46: Natec Medical Basic Information And Sales Area

Table 47: Natec Medical. Products Portfolio

Table 48: Spectranetics Basic Information And Sales Area

Table 49: Spectranetics. Products Portfolio

Table 50: HEXACATH Basic Information And Sales Area

Table 51: HEXACATH. Products Portfolio

Table 52: Alvimedica Basic Information And Sales Area

Table 53: Alvimedica. Products Portfolio

Table 54: Lepu Medical Basic Information And Sales Area

Table 55: Lepu Medical. Products Portfolio

Table 56: Demax Medical Basic Information And Sales Area

Table 57: Demax Medical. Products Portfolio

Table 58: Cardionovum Basic Information And Sales Area

Table 59: Cardionovum. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Drug-eluting PTA Balloon Dilatation Catheter Market Value (USD Million) By Region

Table 65: Global Drug-eluting PTA Balloon Dilatation Catheter Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Drug-eluting PTA Balloon Dilatation Catheter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	8.37 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acotec; Boston Scientific; Abbott; Terumo Europe; MicroPort Scientific; Medtronic; Cordis; B. Braun Melsungen; Natec Medical; Spectranetics; HEXACATH; Alvimedica; Lepu Medical; Demax Medical; Cardionovum
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options